Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
3
Bullish
8
Bearish
30
Neutral
3
Bullish
13
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
Bearish
27
Neutral
0
Bullish
5
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY25
Investor Presentation
Q2 FY22
Investor Presentation
Q1 FY22
Investor Presentation
Q1 FY21
Investor Presentation
Q2 FY20
Investor Presentation
Q2 FY20
Shivalik Rasayan Ltd (SHIVALIK) is currently trading at 298.75 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shivalik Rasayan Limited is an Indian manufacturer focused on agrochemicals, active pharmaceutical ingredients (APIs) and pharmaceutical formulations, best known for organophosphate insecticides such as Dimethoate Technical and Malathion Technical, and holds a significant strategic stake in associate Medicamen Biotech Limited which is consolidated into group results. For FY26 the company reported consolidated revenue near Rs. 36,800 lakhs, up materially versus the prior year, while both standalone and consolidated net profits declined year-on-year, compressing net margins; the audited results were issued with an unmodified opinion by the statutory auditors, indicating clean audit outcomes. Operational scale increased through commissioning of the Dahej-III Agro & Specialty Chemical Plant and a 2,000 MT per annum insecticide/fungicide block launched in FY24, indicating purposeful manufacturing capacity expansion and a shift toward higher volume specialty chemical production to support growth. Balance sheet and cash dynamics diverged between standalone and consolidated statements: consolidated assets and cash improved materially while standalone cash fell sharply to Rs. 310.36 lakhs; the Board recommended a final dividend of 10% for FY26 and reconstituted governance committees following a director resignation and internal auditor change.
Over the past 52 weeks, Shivalik Rasayan Ltd has traded between a low of ₹206.00 and a high of ₹474.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shivalik Rasayan Ltd has a market capitalization of approximately 500.85. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shivalik Rasayan Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.50 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 500.85 Cr, Shivalik Rasayan Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shivalik Rasayan Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shivalik Rasayan Ltd is 25.50. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Two special resolutions approving a preferential issue of up to 3,72,000 equity shares (public category) and up to 9,48,000 fully convertible warrants (promoter and public categories).
The board approved raising up to ₹33 crore via a preferential issue of up to 3,72,000 equity shares and 9,48,000 fully convertible warrants at ₹250 each.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
501 Cr
Moderate Risk
25.5
18.4
-3.5
0.8
474.20
206.00
Sales CAGR
Profit CAGR
ROE
ROCE
